Publications (55) Juan Luis Delgado Marin publications

2024

  1. Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study

    International Breastfeeding Journal, Vol. 19, Núm. 1

  2. Comparison of different methods of first-trimester screening for preterm pre-eclampsia: cohort study

    Ultrasound in Obstetrics and Gynecology, Vol. 64, Núm. 1, pp. 57-64

  3. Heterogeneity of mesenchymal cells in human amniotic membrane at term

    Histology and histopathology, Vol. 39, Núm. 5, pp. 573-593

  4. Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term: protocol of the PE37 study

    BMJ Open, Vol. 14, Núm. 3

  5. The impact of early versus delayed cord clamping on hematological and cardiovascular changes in preterm newborns between 24 and 34 weeks’ gestation: a randomized clinical trial

    Archives of Gynecology and Obstetrics, Vol. 309, Núm. 6, pp. 2483-2490

2023

  1. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain

    Ultrasound in Obstetrics and Gynecology, Vol. 62, Núm. 4, pp. 522-530

  2. Pravastatin reduces plasma levels of extracellular vesicles in pregnancies at high risk of term preeclampsia

    Frontiers in Pharmacology, Vol. 14

  3. Subjective well-being, happiness, and environmental health factors related to women planning a pregnancy or pregnant, using mobile health intervention

    Digital Health, Vol. 9

2022

  1. Clinical phenotypes for risk stratification in small-for-gestational-age fetuses

    Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 4, pp. 490-496

  2. Factors Involved in Endothelial Dysfunction Related to Angiogenic Disbalance and Oxidative Stress, in Women at High Risk of Term Pre-Eclampsia

    Antioxidants, Vol. 11, Núm. 7

  3. Parto pretérmino

    Obstetricia y ginecología (Elsevier), pp. 100-105

  4. STATIN trial: predictive performance of competing-risks model in screening for pre-eclampsia at 35–37 weeks' gestation

    Ultrasound in Obstetrics and Gynecology, Vol. 59, Núm. 1, pp. 69-75

  5. Treatment with natalizumab during pregnancy in multiple sclerosis: The experience of implementing a clinical practice protocol (NAP-30)

    Multiple Sclerosis and Related Disorders, Vol. 66

2021

  1. Congenital infection of SARS-CoV-2 in live-born neonates: a population-based descriptive study

    Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1521.e1-1521.e5

  2. Diabetes gestacional

    Guía de manejo de la patología perinatal (You and Us), pp. 67-81

  3. Gestation and COVID-19: clinical and microbiological observational study (Gesta-COVID19)

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

  4. Gestational age-specific reference ranges for the sFlt-1/PlGF immunoassay ratio in twin pregnancies

    Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 288-296

  5. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 257-265

2020

  1. Follow-up recommendations for the “fourth trimester” in women with vascular and metabolic complications during pregnancy. Consensus Document of SEC, SEMERGEN, semFYC, and SEGO

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 38-46

  2. Is it possible to predict late antepartum stillbirth by means of cerebroplacental ratio and maternal characteristics?

    Journal of Maternal-Fetal and Neonatal Medicine, Vol. 33, Núm. 17, pp. 2996-3002